Alterity Therapeutics-ADRATHE
13F holders, Q3 2025 (September 30)16holders +5
6new positions
1sold out
1famous investor
$3.76avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, up 5 from Q2 2025. 6 opened new positions and 1 sold out. The largest holders were Twin Lakes Capital Management, LLC ($524K), Morgan Stanley ($258K) and HB Wealth Management, LLC ($220K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $324K |
| Exits | 1 | $537K |
All 13F filers, Q2 2025 → Q3 2025: 245,532 shares bought and 132,763 shares sold, net +112,769 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Twin Lakes Capital Management, LLC | 0.24% | Add +2250.3% | 139,258 | $524K |
| Morgan Stanley | 0.00% | Add +17.8% | 68,682 | $258K |
| HB Wealth Management, LLC | 0.00% | New | 58,460 | $220K |
| Greenleaf Trust | 0.00% | Add +88.2% | 32,000 | $120K |
| Citadel Advisors | 0.00% | New | 22,144 | $83K |
| BNP Paribas Financial Markets | 0.00% | Reduce -10.8% | 7,309 | $27K |
| Acadian Asset Management LLC | 0.00% | New | 4,799 | $18K |
| Rhumbline Advisers | 0.00% | Add +581.5% | 886 | $3K |
| Citigroup Inc. | 0.00% | New | 636 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 181 | $889 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -71.8% | 177 | $666 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $150 |
| Farther Finance Advisors, LLC | 0.00% | New | 22 | $83 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $23 |
| Danske Bank A/S | 0.00% | No change | 1 | $4 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.